Pertussis Vaccine Market analysis by Top Manufacturers: Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Astellas Pharma, Minhai Biotechnology etc

The Pertussis Vaccine Market report provides detailed profile assessments and current scenario revenue projections for the most promising industry participants.

DUBLIN, United States - February 12, 2019 /MarketersMedia/ —

The global Pertussis Vaccine Market is expected to increase in the future. The pertussis vaccine protects against whooping cough. There are two main types of pertussis vaccine: acellular vaccines and whole-cell vaccines. The whole-cell vaccine is almost 78% effective, whereas the acellular vaccine is 71–85% effective. The pertussis vaccine is mostly available in combination with diphtheria and tetanus vaccines. The vaccine is listed on the World Health Organization’s List of Essential Medicine for Children.

Get Exclusive Sample of Report on Pertussis Vaccine market having 91 pages, profiling more than TOP 5 Market Players and supported with tables and figures is available at https://www.inforgrowth.com/samplerequest/r/964098/global-pertussis-vaccine-market-research-repor

Following Top Companies are mentioned in this Pertussis Vaccine Market Report:
Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Astellas Pharma, Minhai Biotechnology, Wuhan Institute of Biological Products, Changchun Changsheng Life Sciences etc.

Global Pertussis Vaccine Market Research Report 2019 include all basic information related to the global Industry and forecast till 2025. The Pertussis Vaccine Market research report serves as a repository of analysis and information for every aspect of the market, including regional markets, technology, types, and applications. The objectives of this study are to define, segment, and project the size of the market based on company, product type, end user and key regions.

Market Segmentation:
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Whole-cell vaccines, Acellular vaccines

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users,
Children, Adults

The Report Covers Following Regions: North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

Request For Special Discount:
https://www.inforgrowth.com/requestdiscount/r/964098/global-pertussis-vaccine-market-research-repor

Research and Development of this Report:
The Pertussis Vaccine Market Report Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out. In the end, the report makes some important proposals for a new project of Pertussis Vaccine Market before evaluating its feasibility. Overall, the report provides an in-depth insight of 2013-2025 global and Southeast Asia Pertussis Vaccine industry covering all important parameters.

Research methodology of Pertussis Vaccine Market:
Research study on the Pertussis Vaccine Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.

The study objectives of this report are:
To analyze and study the global Pertussis Vaccine Market capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Pertussis Vaccine manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the Pertussis Vaccine Market growth.
and more…

View Complete Report with Table of Content:
https://www.inforgrowth.com/r/964098/global-pertussis-vaccine-market-research-repor

Contact Info:
Name: Rohan
Organization: InForGrowth
Address: 6400 Village Pkwy suite # 104, Dublin, CA 94568, USA
Phone: +1-909-329-2808
Website: https://www.inforgrowth.com/

Source URL: https://marketersmedia.com/pertussis-vaccine-market-analysis-by-top-manufacturers-sanofi-pasteur-gsk-mitsubishi-tanabe-pharma-astellas-pharma-minhai-biotechnology-etc/481743

Source: MarketersMedia

Release ID: 481743

Latest News

Malaysia's Mahathir says no timetable for handing over power

May 24, 2019

PUTRAJAYA, Malaysia — Malaysian Prime Minister Mahathir Mohamad defended his government's record on the anniversary of its election victory Thursday and reiterated he will hand over power to his successor Anwar Ibrahim though he wasn't clear on when. Mahathir's four-party alliance ousted the coalition that has been in power since independence in 1957 amid anger over then-leader Najib Razak's massive financial scandal and the rising cost of living. But euphoria over the victory has faded and the new government has been accused of backsliding on reform promises in its election manifesto. Mahathir told foreign journalists there had been hiccups in...

Singapore reportedly criminalizes publication of fake news

May 24, 2019

SINGAPORE — Singapore reportedly has passed a law criminalizing publication of fake news and allowing the government to block and order the removal of such content. The Protection from Online Falsehoods and Manipulation Bill passed Wednesday night by a vote of 72-9, a lawmaker with the opposition Worker's Party, Daniel Goh, said on Twitter. The law bans falsehoods that are prejudicial to Singapore or likely to influence elections and requires service providers to remove such content or allows the government to block it. Offenders could face a jail term of up to 10 years and hefty fines. Opponents in Parliament...

Malaysia cuts interest rate for first time in 3 years

May 24, 2019

KUALA LUMPUR, Malaysia — Malaysia's central bank cut interest rates Tuesday for the first time in nearly three years to help support growth and counter risks from a global slowdown, trade tensions and extended weakness in commodity prices. Bank Negara Malaysia says it decided to reduce its overnight policy rate, used by banks to calculate interest rates, to 3% from 3.25%. The rate was last cut by a quarter-basis point to 3% in July 2016, but was raised back to 3.25% in January 2018. The central bank forecast the economy will expand between 4.3-4.8% this year. It said in a...

Boeing 737 Max 8 woes crimp Asian airlines' growth plans

May 24, 2019

SINGAPORE — Asian airlines are cutting routes, revamping their schedules and leasing extra aircraft to fill gaps left by the grounding of Boeing 737 Max 8s after deadly crashes in Indonesia and Ethiopia killed 346 people. So far, regional carriers have managed to avoid major disruptions, but analysts expect that idling the Max 8s, a fuel-efficient update of Boeing's popular 737, will crimp growth plans in the near future. As investigations into the crashes continue, Boeing anticipates a $1 billion increase in costs related to the 737 Max, including fixing software implicated in the disasters, adding pilot training and compensating...

Axiata, Telenor in merger talks to create telecoms giant

May 24, 2019

KUALA LUMPUR, Malaysia — Malaysia's Axiata Group Berhad said Monday it is in talks with Norway's Telenor ASA to merge their Asian operations to create one of the world's top telecommunications giants with some 300 million customers in nine countries. Axiata said in a statement that Telenor is expected to hold a 56.5 percent stake and Axiata 43.5 percent in the proposed "merger of equals." Both companies operate in Malaysia, Thailand, Myanmar, Bangladesh and Pakistan. Axiata also has a presence in India, Sri Lanka, Nepal, Cambodia and Indonesia but it said its Bangladesh operation would be excluded. Axiata said merged...